Lung Institute | Buffalo New York

Emphysema Treatment Near Buffalo, NY

At just over 3 hours’ drive from Buffalo, NY, Pittsburgh, PA, leads lung disease research with programs like those at the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh. ThePittsburgh Lung Institute clinic treats interstitial lung disease and other serious lung disorders including COPD, emphysema, chronic bronchitis, pulmonary fibrosis and black lung.

Lung disease is the third leading cause of death in the United States, and most traditional treatment options only treat the symptoms rather than the disease itself. Most who have been diagnosed with lung disease are prescribed a bronchodilator and daily medication to clear the respiratory path and reduce coughing. The advent of cellular therapy is a game-changer for those with lung disease.

To date the Lung Institute has treated over 1,000 patients with cellular therapy, and is excited to increase the number of improved lives with the addition of the Pittsburgh Clinic. Dr. Jack Coleman, Jr, MD, is the Medical Director for the Lung Institute in Pittsburgh. He earned his medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. Dr. Coleman is a board certified in physician and ensures that all treatments and staff will follow strict standards with the highest excellence in personalized patient care.

What is a Stem Cell?

Cells are the building blocks of life; they are essential to every living organism. They are able to self-renew and replicate—with the ability to form every type of tissue or organ in the body. Adult cells from one organ are able to create tissue for another organ; this is called plasticity. This is key to their function in regenerative medicine.

How Does the Lung Institute use Cells?

The Lung Institute offers cellular therapys for many of the major pulmonary conditions, including chronic obstructive pulmonary disorder (COPD), emphysema, chronic bronchitis, pulmonary fibrosis and interstitial lung disease. The cells used by the Lung Institute are autologous, which means they come from the patient’s own body. The cells are extracted from the patient’s own bone marrow or blood (venous) depending on the patient’s current condition and health history. Adult cells have the capacity to form many types of differentiated cells, so when the cells are returned to the patient, they will target the damaged tissue, which leads to improved lung function in patients with a chronic lung disease. Our minimally invasive, outpatient stem cell procedures are changing lives by helping patients breathe easier.

About the Lung Institute

For those who are seeking treatment for interstitial lung disease near Buffalo, New York, the Lung Institute’s Pittsburgh clinic might be the answer. If you or a loved one suffers from a lung disease, contact one of our patient coordinators today at (800) 729-3065 to see if you qualify.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.